Inventor · disambiguated record
Oliver Nussbaumer
Also filed as: NUSSBAUMER OLIVER
6 granted patents·17 pending applications·1 citations·filing 2016–2025
68Inventor score
Top patents by PatentIndex Score
23 records- 0170US12458698B2Expansion of γδ T cells, compositions, and methods of use thereofKING S COLLEGE LONDON·Filed 2023·Granted Nov 4, 2025·0 cites·20 claims
- 0268US11655453B2Expansion of γδ T cells, compositions, and methods of use thereofKING S COLLEGE LONDON·Filed 2018·Granted May 23, 2023·1 cites·17 claims
- 0367US2024082308A1Methods for treating myeloid malignanciesGAMMADELTA THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 0466US12486313B2Gene armoringGAMMADELTA THERAPEUTICS LTD·Filed 2024·Granted Dec 2, 2025·0 cites·30 claims
- 0564US2025122264A1Btnl3/8 targeting constructs for delivery of payloads to the gastrointestinal systemKING S COLLEGE LONDON·Filed 2024·Application pending·0 cites
- 0664US2023099491A1Expansion of non-haematopoietic tissue-resident gamma delta t cells and uses of these cellsCANCER RESEARCH TECH LTD·Filed 2022·Application pending·0 cites
- 0763US2025352570A1Methods for treating myeloid malignanciesGAMMADELTA THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 0861US2025025555A1Cells expressing an anti-mesothelin carGAMMADELTA THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0957US2021290674A1Methods for treating myeloid malignanciesGAMMADELTA THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1057US2025340842A1Method for expanding gamma delta t cellsGAMMADELTA THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 1156US12152064B2BTNL3/8 targeting constructs for delivery of payloadsKING S COLLEGE LONDON·Filed 2019·Granted Nov 26, 2024·0 cites·15 claims
- 1250US2024197875A1Novel methodGAMMADELTA THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1350US2023159638A1Ex vivo gamma delta t cell populationsGAMMADELTA THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1450US2023090901A1Novel antibodiesGAMMADELTA THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1548US11618885B2Expansion of non-haematopoietic tissue-resident gamma delta T cells and uses of these cellsCANCER RESEARCH TECH LTD·Filed 2016·Granted Apr 4, 2023·0 cites·14 claims
- 1648US2023227777A1Methods for isolating gamma delta t cellsGAMMADELTA THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1747US2021015867A1Lymphocytes expressing heterologous targeting constructsGAMMADELTA THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 1847US2023330143A1Immunotherapy compositionGAMMADELTA THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1943US2022403025A1Therapeutic uses of anti-tcr delta variable 1 antibodiesGAMMADELTA THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 2042US12460180B2Methods for isolating and expanding cellsGAMMADELTA THERAPEUTICS LTD·Filed 2019·Granted Nov 4, 2025·0 cites·16 claims
- 2140US2023149459A1V delta1+ t cells for the treatment of myeloid malignanciesGAMMADELTA THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 2239US2022290101A1Ex vivo gamma delta t cell populationsGAMMADELTA THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 2338US2022010277A1Methods for isolating and expanding cellsGAMMADELTA THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →